Patient-Specific Molecular Alterations Are Associated With Metastatic Clear Cell Renal Cell Cancer Progressing Under Tyrosine Kinase Inhibitor Therapy
Oncotarget - United States
doi 10.18632/oncotarget.18200
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 25, 2017
Authors
Publisher
Impact Journals, LLC